Premium
A Three‐dimensional Dy III ‐based Metal‐organic Framework: Smart Drug Carrier and Anti‐lung Cancer Activity
Author(s) -
Liu FengJi,
Xu BingMei
Publication year - 2018
Publication title -
zeitschrift für anorganische und allgemeine chemie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.354
H-Index - 66
eISSN - 1521-3749
pISSN - 0044-2313
DOI - 10.1002/zaac.201800136
Subject(s) - metal organic framework , infrared spectroscopy , elemental analysis , carboxylate , lanthanide , powder diffraction , drug delivery , nuclear chemistry , crystallography , chemistry , materials science , tricarboxylic acid , metal , drug , stereochemistry , inorganic chemistry , nanotechnology , organic chemistry , adsorption , ion , psychology , psychiatry , enzyme , citric acid cycle
A 3D lanthanide metal‐organic framework (MOF) with the formula [Dy 2 (L) 2 (H 2 O) 2 ] n ( 1 ) (H 3 L = biphenyl‐3,4′,5‐tricarboxylic acid) was synthesized under solvothermal conditions and structurally characterized by elemental analysis, powder X‐ray diffraction analysis, infrared spectroscopy, and single‐crystal X‐ray diffraction analysis. Compound 1 features a 3D porous framework based on 1D rod‐shaped Dy III ‐carboxylate chains. The efficient encapsulation and controllable release of an anticancer drug (5‐Fu) make it a promising drug delivery host. Furthermore, the GCMC simulation was used to probe the drug‐framework interaction at the atomic lever. The in vitro anti‐lung cancer activity of 1 and 5‐Fu loaded 1a were also evaluated using MTT assay.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom